If you are like many small and medium-sized manufacturers, finding good help has been a pain point for many years, and it has become even more difficult during the Covid-19 pandemic. The market forces driving that dynamic are not likely to change soon.

Covid-19 has dealt most businesses a heavy blow, but the pandemic has at least one under-acknowledged upside.

If you were to contact a group of recycling professionals, as one recent survey did, and ask them to list all the ways that consume

During the past few years, I have written more than a few blogs and papers looking at manufacturing pro

Unlike Covid-19, remote audits aren’t unprecedented. Remote audits didn’t start with the pandemic, although it has forced more companies to use them than previously. At MasterControl, we’ve been doing remote audits for years for our international customers.

A new digital era of business-to-business (B2B) sales and marketing is upon us. It’s driven by corporate customer demand for online access to their suppliers’ offerings and expertise.

Real-world, face-to-face communication—complete with eye contact, body language, and other important sources of information—is a rarity in business today, and the potential for failing to convey an intended message or giving the wrong impression has grown.

Are the days of standard industrial robots numbered? Absolutely not. In part one of this series, we looked at the unique attribute of cobots.

As commercialization strategies evolve amid Covid-19, and supply chains continue to trend toward diversification, the only way for businesses to control their destiny is to double down on quality standards.

The U.S. Department of Defense and more than 80 companies, universities, states, and research institutes will invest at least $275 million during the next seven years to scale up the microbial production of biomolecules.